Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and ...

Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a ...

Soligenix Inc.’s phase IIa study of SGX-945 (dusquetide) for treating oral ulcers in those with Behçet's disease showed biological efficacy in the proof-of-concept study. The positive results ...

Soligenix ( (SNGX)) has shared an announcement. On July 31, 2025, Soligenix announced the completion of its Phase 2a proof of concept study for SGX945 (dusquetide) in treating Behçet’s Disease, ...

Five Dogs of the Dow stocks offer big yields, a degree of safety from tariffs, and a long history of corporate success.

The Village Voice previews the book launch of Pulitzer Prize nominee Ed Park’s short story collection “An Oral History of Atlantis.” ...

An oral history of Roger Corman's unreleased Fantastic Four movie As The Fantastic Four approaches its 30th anniversary, we talked to the actors, writer, and director behind Roger Corman's ...

All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® vs. placebo for 36 weeks, followed by an open label extension of active Xanamem for up to 24 months ...

Lelo’s Ora 3 is an oral sex stimulator that doesn’t rely on suction air technology.

There is magic at work in this week's batch of new books. Not just the old literary sorcery by which words summon worlds for readers, but also literal, honest-to-goodness magic: angels, conjurers ...